STAT

Opinion: A road map for including Latinos and African Americans in Alzheimer’s research

Small gains are being made across the country to narrow disparities in the diagnosis and treatment of Alzheimer's disease among African Americans and Latinos. But much more needs to be…

Alzheimer’s disease is the only leading cause of death in the U.S. that is still on the rise and that does not have a current effective treatment or cure. The limited inclusion of Latinos and African Americans in research will only worsen the outlook, though the success of efforts bubbling up across the country could help us keep up with the disease.

The face of Alzheimer’s is changing, largely because the No. 1 risk factor for it is advanced age. By 2030, the number of Latinos age 65 and the number of African Americans will have , compared to 65% among non-Hispanic whites. As Sen. Amy Klobuchar (D-Minn.) , by 2030 Latinos and African Americans will make up nearly 40% of the 8.4 million Americans living with Alzheimer’s.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks